PET and the role of in vivo molecular imaging in personalized medicine

References

• Lander ES, Linton LM, Birren B etal Initial sequencing and analysis of the human genome. Nature 409(6822), 860–921 (2001).
   PubMed Web of Science ®Google Scholar
• Robson B, Gamier J. The future of highly personalized healthcare. In: Future of Health Technology Bushko RG (Ed.), IOS Press, Amsterdam, The Netherlands, 163–174 (2002).
   Google Scholar
• Meyer JM, Ginsburg GS. The path to personalized medicine. Curr: Opin. Chem. Biol. 6,434-438 (2002).
   Google Scholar
• Jain K.K. Personalized medicine. CUI7: Opin. Mal Ther: 4(6), 548–558 (2002).
   Google Scholar
• •A popular definition of personalized medicine.
   Google Scholar
• Mancinelli 1, Cronin M, Sadée W Pharmacogenomics: the promise of personalized medicine. AAPS PharmSci 2(1), 1–12 (2000).
   Google Scholar
• Ross JS, Ginsburg GS. Integrating diagnostics and therapeutics: revolutionizing drug discovery and patient care. Drug- Discov Today7(16), 859–864 (2002).
   PubMedGoogle Scholar
• Roses AD. Pharmacogenetics and the practice of medicine. Nature 405 (6788), 857–865 (2000).
   PubMedGoogle Scholar
• Chen GY, Uttamchandani M, Lue RY etal Array-based technologies and their applications in proteomics. CUI7: Top. Merl Chem. 3(6), 705–724 (2003).
   Google Scholar
• •Good overview of array-based screening technologies.
   Google Scholar
• Shipp MA, Ross KN, Tamyo P eta]. Diffuse large B-cell lymphoma outcome prediction by gene expression profiling and supervised machine learning. Nature Merl 8(1), 68–74 (2002). Excellent example of the power of disease gene profiling.
   Google Scholar
• Phelps ME. PET: the merging of biology and imaging into molecular imaging. Nucl. Merl 41(4), 661–681 (2000).
   Google Scholar
• •An introduction to applications of positron emission tomography (PET) imaging.
   Google Scholar
• Czemin J, Phelps ME. Positron emission tomography scanning: current and future applications. Ann. Rev Med. 53,89–112 (2002).
   PubMedGoogle Scholar
• •How PET imaging may be used in the future.
   Google Scholar
• Weissleder R, Mahmood U. Molecular imaging. Radiology219 (2), 316–333 (2001).
   PubMed Web of Science ®Google Scholar
• •A cross-modality overview of molecular imaging.
   Google Scholar
• Phelps ME. Positron emission tomography provides molecular imaging of biological processes. Proc. Natl Acad. Sci. USA 97(16), 9226–9233 (2000). An excellent insight into the power of PET molecular imaging.
   Google Scholar
• Luker GD, Piwnica-Worms D. Beyond the genome: molecular imaging in vivo with PET and SPECT. Acad. Radial. 8(1), 4–14 (2001).
   PubMedGoogle Scholar
• Gambhir SS, Czemin J, Schqimmer J, Silverman DHS, Edward Coleman R, Phelps ME. A tabulated summary of the FDG PET literature. j Nucl. Merl 42, 1S-93S (2001).
   Google Scholar
• ••A comprehensive summary of the clinicalapplication of FDG PET imaging.
   Google Scholar
• Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nature Rev. 2,683-693 (2002). Excellent overview of molecular imaging in cancer with PET.
   Google Scholar
• Vranjesevic D, Filmont JE, Meta J eta]. Whole-body 18F-FDG PET and conventional imaging for predicting outcome in previously treated breast cancer patients. J. Nucl. Med 43(3), 325–329 (2002).
   Google Scholar
• Schwimmer J, Essner R, Patel A et al A review of the literature for whole-body FDG PET in the management of patients with melanoma. Quart. J. Nucl. Merl 44(2), 153–167 (2000).
   Google Scholar
• Meta J, Seltzer M, Schiepers C etal Impact of 18F-FDG PET on managing patients with colorectal cancer: the referring physician's perspective. J. Nucl. Med. 42 (4), 586–590 (2001).
   Google Scholar
• Yap CS, Seltzer MA, Schiepers C eta]. Impact of whole-body 18F-FDG PET on staging and managing patients with breast cancer: the referring physician's perspective. J. Nucl. Med 42(9), 1334–1337 (2001).
   Google Scholar
• Dimitrakopoulou-Strauss A, Strauss LG. PET imaging of prostate cancer with 11C-acetate. J. Nucl. Med 44(4), 556–558 (2003).
   Google Scholar
• Ham T 11C-Choline and 2-deoxy-2-[18F]flouro-D-glucose in tumour imaging with positron emission tomography. Mal Imaging Biol. 4,267–273 (2002).
   PubMedGoogle Scholar
• Shoup TM, Olson J, Hoffman JM eta]. Synthesis and evaluation of [18F1-amino-3-fluorocyclobutane-1 -carboxylic acid to image brain tumors. J: Nucl. Merl 40, 331–338 (1999).
   Google Scholar
• •A candidate oncology PET tracer beyond FDG.
   Google Scholar
• McDonald DM, Choyke PL. Imaging of angiogenesis: from microscope to clinic. Nature Merl 9(6), 713–725 (2003).
   PubMed Web of Science ®Google Scholar
• Van de Wiele C, Lahorte C, Oyen W etal Nuclear medicine imaging to predict response to radiotherapy: a review. Int. J: Radiat. Oncol Biol. Phys. 55(1), 5–15 (2003).
   Google Scholar
• Brady F, Sajinder K, Luthra GD eta]. Radiolabeled tracers and anticancer drugs for assessment of therapeutic efficacy using PET CL117: Pharm. Des. 7,1863-1892 (2001). living patients with Alzheimer's disease. Am Ceriatr Psychiatry 10(1), 24–35 (2002). Website Website
   Google Scholar
• Hoffman JM, Menkens AE. Molecular imaging in cancer: future directions and goals of the National Cancer Institute. Acad. Radio. 7(10), 905–907 (2000).
   PubMedGoogle Scholar
• Mari C, Strauss WH. Detection and characterization of hibernating myocardium. Nucl. Med. Commun. 23(4), 311–322 (2002).
   Google Scholar
• Rudd JH, Warburton EA, Fryer TD et al Imaging atherosclerotic plaque inflammation with [18F1-fluorodeoxy-glucose positron emission tomography. Circulation 105 (23), 2708–2711 (2002).
   Google Scholar
• Nweberg A, Cotter A, Udeshi M et al Brain metabolism in the cerebellum and visual cortex correlated with neuropsychological testing in patients with Alzheimer's disease. Nucl. Med. Commun. 24(7), 785–790 (2003).
   Google Scholar
• Mathis CA, Wang U, Holt DP, Huang GF, Debnath ML, Klunk WE. Synthesis and evaluation of 11C-labeled 6-substituted 2-arylbenzothiazoles as amyloid imaging agents. J. Med. Chem. 46(13), 2740–2754 (2003).
   Google Scholar
• •Consideration of pharmacoeconomics in PET imaging.
   Google Scholar
• Gambhir SS, Schwimmer J. Economic evaluation studies in nuclear medicine: a methodological review of the literature. Quart. Nucl. Med. 44(2), 121–137 (2000).
   Google Scholar